Get the Stockscreener App
0.531
3.91%
0.02
Rallybio Corp stock is traded at $0.531, with a volume of 474.88K.
It is up +3.91% in the last 24 hours and up +3.83% over the past month.
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
See More
Previous Close:
$0.511
Open:
$0.518
24h Volume:
474.88K
Relative Volume:
0.18
Market Cap:
$22.10M
Revenue:
-
Net Income/Loss:
$-74.56M
P/E Ratio:
-0.2899
EPS:
-1.8316
Net Cash Flow:
$-60.27M
1W Performance:
-0.75%
1M Performance:
+3.83%
6M Performance:
-37.11%
1Y Performance:
-55.38%
1-Day Range:
$0.4701
$0.565
1-Week Range:
$0.4701
$0.585
52-Week Range:
$0.2201
$1.25
Rallybio Corp Stock (RLYB) Company Profile
Name
Rallybio Corp
Sector
Industry
Phone
203- 859-3820
Address
234 CHURCH STREET, NEW HAVEN
Compare RLYB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.531 | 21.96M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-15-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-07-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-17-23 | Initiated | H.C. Wainwright | Buy |
| Apr-10-23 | Initiated | Wedbush | Outperform |
| Dec-09-22 | Initiated | JP Morgan | Overweight |
| Feb-22-22 | Initiated | JMP Securities | Mkt Outperform |
| Aug-23-21 | Initiated | Cowen | Outperform |
| Aug-23-21 | Initiated | Evercore ISI | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
View All
Rallybio Corp Stock (RLYB) Latest News
Rallybio Corporation stock daily chart insightsBuy Strategy Review With Performance Summary - Newser
Rallybio's Narrowing Losses and Industry Outperformance: A Biotech Turnaround Play? - AInvest
Rallybio First Half 2025 Earnings: US$0.43 loss per share (vs US$0.83 loss in 1H 2024) - uk.finance.yahoo.com
Price action breakdown for Rallybio CorporationTechnical Entry Plan with Risk Minimization - Newser
Detecting support and resistance levels for Rallybio CorporationSector-Wise Equity Performance Trend Forecast - Newser
Is a relief rally coming for Rallybio Corporation holdersEntry Opportunity Screener with Confirmation - Newser
What makes Rallybio Corporation stock price move sharplyPattern Breakout Prediction for Short Term - Newser
Historical volatility pattern of Rallybio Corporation visualizedBreakout Watcher with Entry and Exit Alerts - Newser
Rallybio Corporation Reports Q2 2025 Financial Results - TipRanks
Rallybio Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Rallybio shares fall 3.41% intraday after Q2 revenue decline. - AInvest
Rallybio Corp SEC 10-Q Report - TradingView
Rallybio Q2: RLYB116 confirmatory PK/PD study on track, cash runway into mid-2027. - AInvest
Rallybio Q2 Revenue Down to $0.2mln, Net Loss Narrows to $9.7mln - AInvest
Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance
Intraday pattern recognizer results for Rallybio CorporationStock Entry Point Planner with Volume Spike - Newser
Rallybio Corporation Stock Performance After Earnings: Historical InsightsFree Technical Entry Strategy for Beginners - Newser
Is Rallybio Corporation a Top Dividend Stock to Watch in 2025Free Entry Alert With Low Drawdown Strategy - Newser
What are analysts’ price targets for Rallybio Corporation in the next 12 monthsTrack top-performing stocks effortlessly - Jammu Links News
Why is Rallybio Corporation stock attracting strong analyst attentionUnlock your trading potential with expert tips - Jammu Links News
Using data models to predict Rallybio Corporation stock movementSwing Trade Entry and Exit Point Analysis - Newser
What the charts say about Rallybio Corporation todayPredictive System for Long-Term Stock Forecast - Newser
What MACD and RSI say about Rallybio CorporationFree Smart Trade Plans With Risk Protection - Newser
Is it the right time to buy Rallybio Corporation stockSuperior investment outcomes - Jammu Links News
Is Rallybio Corporation stock overvalued or undervaluedMaximize returns with disciplined investment techniques - Jammu Links News
How volatile is Rallybio Corporation stock compared to the marketTurbocharged investment results - Jammu Links News
What is the dividend policy of Rallybio Corporation stockLightning-fast growth - Jammu Links News
What analysts say about Rallybio Corporation stockUnlock powerful portfolio management tools - Jammu Links News
What are Rallybio Corporation company’s key revenue driversSkyrocketing returns - Jammu Links News
What are the technical indicators suggesting about Rallybio CorporationFree Capital Growth Strategies - Jammu Links News
How strong is Rallybio Corporation company’s balance sheetAchieve rapid returns with smart investment plans - Jammu Links News
Rallybio Corporation Stock Analysis and ForecastExplosive portfolio gains - Jammu Links News
What catalysts could drive Rallybio Corporation stock higher in 2025Massive portfolio appreciation - Jammu Links News
Is Rallybio Corporation a growth stock or a value stockOverwhelming financial success - Jammu Links News
How many analysts rate Rallybio Corporation as a “Buy”Maximize gains with data-driven stock picks - Jammu Links News
Is Rallybio Corporation a good long term investmentExceptional market performance - Jammu Links News
What institutional investors are buying Rallybio Corporation stockInvest smarter with expert trading signals - Jammu Links News
News impact scoring models applied to Rallybio CorporationPattern Recognition Tool for ROI Investors - Newser
Applying chart zones and confluence areas to Rallybio CorporationTechnical Screener for High Growth Stocks - Newser
Visual analytics tools that track Rallybio Corporation performanceMachine Learning Stock Movement Detector - Newser
What machine learning models say about Rallybio CorporationFree Short Term Setup With Predictive Chart - Newser
How Rallybio Corporation stock performs during market volatilityValue Investing Checklist with Entry Signals - Newser
Rallybio Corporation Company’s Quarterly Earnings Growth: What the Numbers SayLong-Term Stock Growth Forecast Insights - Newser
Here's Why Shares in Recursion Pharmaceuticals Surged Today - MSN
Top Risks to Consider Before Buying Rallybio Corporation StockReal Stock Picks With Setup Verification - Newser
Rallybio Corporation stock volume spike explainedSmart Forecast Signals from AI Models - Newser
New Product Launches: Will They Boost Rallybio Corporation Stock in 2025Annual Market Behavior and Sector Summary - Newser
Will Rallybio Corporation bounce back from current supportRisk Controlled Picks With Real Returns Outlined - metal.it
Is Rallybio Corporation stock a good hedge against inflationShort Term Trading Opportunity Watch Sees Shift - metal.it
Should you wait for a breakout in Rallybio CorporationWeekly Chart Watchlist with Trade Guidance - Newser
MACD Cross Could Confirm Trend in Rallybio CorporationPotential Breakout Stock List Published This Week - metal.it
Rallybio Corp Stock (RLYB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
3.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):